Verastem to Present at Molecular Medicine Tri-Conference Symposium “Targeting Cancer Stem Cells in Oncology”
By Sykes24Tracey
CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Verastem, Inc., (NASDAQ: VSTM – News) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced that the company will present at the 2012 Molecular Medicine Tri-Conference Symposium “Targeting Cancer Stem Cells in Oncology.” The presentation is on February 19, 2012 at 2:00pm PT at the InterContinental San Francisco Hotel.
About Verastem, Inc.
Verastem, Inc. (NASDAQ: VSTM – News) is a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is translating discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer.
Forward-looking statements:
Any statements in this press release about future expectations, plans and prospects for the Company constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.
Go here to read the rest:
URL: http://finance.yahoo.com/news/verastem-present-molecular-medicine-tri-210100512.html
Related Post
- VistaGen CEO Issues Update Letter to Stockholders - May 16th, 2012
- Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives - May 16th, 2012
- Research and Markets: Stem Cell Research Products: Opportunities, Tools & Technologies 2012 (Updated) - May 16th, 2012
- Julio C. Voltarelli, Pioneer in Cell Transplantation, Dies at 63 - May 10th, 2012
- Regenerative medicine: Could the ways animals regenerate hair and feathers help restore human fingers and toes? - May 10th, 2012
- Study Identifies Cell Subtypes For Potential Personalized Cellular Therapies - May 10th, 2012
- New England Journal of Medicine Reports on Three Phase III REVLIMID® (lenalidomide) Trials in Patients with Newly ... - May 10th, 2012
- Single cell triggers fibroid uterine tumor - May 7th, 2012
- UCLA scientists measure communication between stem cell-derived motor neurons and muscle cells - May 6th, 2012
- ACT Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration ... - May 2nd, 2012
- Genetically Modified T Cell Therapy Shown to be Safe, Lasting in Decade-Long Penn Medicine Study of HIV Patients - May 2nd, 2012
- First fellowships awarded in new Canadian stem cell and regenerative medicine research program - May 2nd, 2012
- Scientists Have Found a Way to Regenerate Muscle Tissue After a Heart Attack [Medicine] - April 29th, 2012
- Growing up as a neural stem cell: The importance of clinging together and then letting go - April 25th, 2012
- QualityStocks News - Advance Cell Technology Completes Treatment of Third Dry AMD Patient in Phase I/II Clinical Trial - April 22nd, 2012
- ACT Announces Third Dry AMD Patient Treated in Clinical Trial - April 22nd, 2012
- Bellicum Appoints Baylor College of Medicine's David M. Spencer as Chief Scientific Officer - April 14th, 2012
- California Stem Cell Chairman Hans Keirstead Speaks at Prominent Global Emerging Leadership Forum - April 14th, 2012
- Stem cell institute to work with foreign agencies - April 1st, 2012
- Vatican’s Stem-Cell Censorship Sham - March 30th, 2012
- Basketball’s influence on stem cell treatments in sports medicine - March 30th, 2012
- Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation - March 28th, 2012
- Vatican Calls Off Stem-Cell Conference - March 27th, 2012
- Advances in regenerative medicine spark skin cell banking startup - March 22nd, 2012
- Proposition 71 stem cell research funds drying up - March 22nd, 2012
- Bioheart Labs and Stemlogix Veterinary Products Featured in Media - March 22nd, 2012
- Researchers: Stem cell cures are on the way - March 22nd, 2012
- California institute fights to continue stem cell research - March 22nd, 2012
- Biostem U.S., Corporation Continues Building Its Scientific and Medical Board of Advisors With Appointment of Leading ... - March 20th, 2012
- California's stem cell agency ponders a future without taxpayer support - March 19th, 2012
- California's stem cell agency ponders its future - March 19th, 2012
- Bioheart and Ageless Partner to Advance Stem Cell Field With Laboratory Training Programs - March 15th, 2012
- TEDMED 2012 Conference Offers $2 Million in Scholarships to Health and Medicine Leaders and Innovators; Free National ... - March 13th, 2012
- Repairing mutations in human mitochondria - March 13th, 2012
- Correcting human mitochondrial mutations - March 12th, 2012
- UCLA scientists find insulin, nutrition prevent blood stem cell differentiation in fruit flies - March 12th, 2012
- Insulin, Nutrition Prevent Blood Stem Cell Differentiation in Fruit Flies - March 12th, 2012
- Biostem U.S., Corporation Appoints Heart Surgeon, Thomas W. Prendergast, M.D. to Its Scientific and Medical Board of ... - March 12th, 2012
- New Industry Partnership to Strengthen Regenerative Medicine Industry in Canada - March 9th, 2012
- Stem Cell-Seeded Cardiopatch Could Deliver Results for Damaged Hearts - March 8th, 2012
and-developing , and-metastasis- , cell-research , forward-looking , meaning , medicines-for , present-at-the , press , prospects-for , such-as-breast , treat-breast , treatment , verastem 
February 15th, 2012
This author published 527 posts in this site.Share
